December 10, 2021 CDC: Flu virus detections on the rise, early signs vaccination down Influenza virus detections are rising in the U.S., according to health officials.
December 9, 2021 FDA authorizes AstraZeneca COVID antibody treatment for emergency use The U.S. Food and Drug Administration on Wednesday issued emergency use authorization for AstraZeneca's Evusheld.
December 1, 2021 FDA panel endorses first COVID-19 pill A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the coronavirus.
November 30, 2021 Merck COVID-19 pill: FDA panel weighs safety, effectiveness Government health advisers on Tuesday weighed the benefits and risks of a closely watched drug from Merck that could soon become the first U.S.-authorized pill for patients to take at home to treat COVID-19.
November 30, 2021 University of Oxford on omicron: No proof COVID-19 vaccines won't prevent against severe disease The University of Oxford said Tuesday there was no evidence that current COVID-19 vaccines would not continue to protect against severe disease from the omicron variant.
November 24, 2021 Trump's surgeon general: US needs to fight antimicrobial resistance to prevent next pandemic Dr. Jerome Adams, who served as U.S. surgeon general under former President Trump, is calling for action to combat the threat of antimicrobial resistance.
November 24, 2021 Holiday drinking: How much alcohol should you have this season? The holiday season has arrived, and with it comes temptation. Thanksgiving stuffing and Christmas cookies seem to lurk at every turn and there seems to be a holiday cocktail party every week from November to Jan. 1.
November 19, 2021 AstraZeneca trials show antibody drug more than 80% effective at preventing COVID-19 COVID-19 vaccine maker AstraZeneca announced Thursday that its antibody drug is more than 80% effective at reducing risk of severe disease or death.
November 17, 2021 FDA plans to authorize Pfizer boosters for all adults before week's end: reports The U.S. Food and Drug Administration (FDA) is expected to authorize booster doses of the Pfizer/BioNTech COVID-19 vaccine for all adults before an influential U.S. advisory panel meets on Friday.
November 17, 2021 Pfizer asks US regulators to authorize experimental COVID-19 pill Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home. COR